The next-generation closure device for interventional treatment of congenital heart disease
is regarded to be biodegradable, yet the corresponding biomaterial technique is still …

The purpose of this report was to develop novel biodegradable occlusion devices for closure
of atrial septal defects (ASD). To manufacture the biodegradable occluders …

Objective To evaluate the safety and feasibility of a modified poly (l‐lactic acid)(PLLA) atrial
septal defect (ASD) occluder. Methods Forty‐five piglets were divided into two groups: an …

Objective Atrial septal defect (ASD) is a general term used to describe an opening in the
atrial septum that divides the two atria; unless the hole is occluded, it can give rise to serious …

Atrial septal defect (ASD) is a common structural congenital heart disease. With the
development of interventional closure devices and transcatheter techniques, interventional …

This study was conducted to evaluate the feasibility, safety, biocompatibility, and
degradation features of a fully biodegradable occluder for closure of atrial septal defect …

Objectives: We sought to test the hypothesis that interventional atrial septal defect (ASD)
closure can be performed safely and effectively using a bioresorbable occluder matrix …

Objectives This study evaluated the feasibility, effectiveness, and safety of a biodegradable
(BD) occluder for closure of ventricular septal defect (VSD) in an acute canine model …

Objective To fabricate a biodegradable occluder for heart defect using the three-dimensional
(3D) printing technique and evaluate its biosafety in an animal model. Methods Occluder …

Transcatheter closure has been widely accepted as a highly effective way to treat abnormal
blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of …